Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New program aims to ease burden on caregivers of cancer and diabetes patients

NCT ID NCT07061652

Symptom relief Sponsor: UNC Lineberger Comprehensive Cancer Center Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now This study
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Aug 11, 2026 · Updated 4 times

Summary

This study tests a program called enCompass Humana, which provides coaching and resources to unpaid caregivers of adults with both cancer and diabetes. The goal is to see if the program is practical and helpful for caregivers, improving their coping skills and reducing loneliness. About 162 caregivers will take part, receiving up to eight coaching sessions and access to an online tool.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
coaching sessions and resource materials
What this could lead to
If successful, this program could provide a practical way to support caregivers, reducing their stress and improving their ability to cope.
What could go wrong
This is a small, early-stage study focused on feasibility, not a proven treatment. The benefits seen so far may not hold up in larger, more diverse groups.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 162 people

The number the study aims to enrol. It can still change while the study runs.

Started

Jul 2025

Expected to finish

May 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 99 years

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: Inclusion Criteria for Caregivers * English-speaking. * Ability to provide written or verbal informed consent to participate in the study; * Willing and able to comply with study procedures based on the judgment of the investigator or protocol designee; * Be at least 18 years of age at the time of consent; and * Identify as an informal (unpaid) caregiver for an adult with a stage II-IV cancer AND diabetes. Inclusion Criteria for patients * English-speaking * Ability to provide informed consent. * Be at least 18 years of age at the time of consent; and * Their identified caregiver is enrolled in the study * Diagnoses: (must have cancer and diabetes) * Have a cancer diagnosis for which they are being actively treated at one of the study sites * Have a cancer diagnosis, stage II-IV solid tumor or any hematologic malignancy * Receiving active cancer treatment s, not including hormonal therapy * Concurrent history of diabetes with need for ongoing management Exclusion Criteria: Exclusion Criteria for Caregivers * Unable to complete self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes; * Existence of another co-morbid disease other than diabetes, which in the opinion of the investigator, prohibits participation in the protocol; * Participation in the intervention development phase of this intervention Exclusion Criteria for patients * Self-report instruments due to illiteracy, neurologic illness, inability to speak or read English, or other causes; * Existence of other co-morbid disease, which in the opinion of the investigator, prohibits participation in the protocol; * Their caregiver does not enroll in the study or withdraws consent

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

cancer diabetes mellitus neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Cancer Diabetes

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    3 sites. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Moffitt Cancer Center

    RECRUITING

    Tampa, Florida, 33612, United States

  • UNC Lineberger Comprehensive Cancer Center

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

  • University of Vermont Cancer Center

    RECRUITING

    Burlington, Vermont, 05401, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.